Title:
IDO1-RELATED VACCINE AND USE THEREOF
Document Type and Number:
WIPO Patent Application WO/2023/226261
Kind Code:
A1
Abstract:
Provided are an IDO1-related vaccine and the use thereof. The IDO1-related vaccine comprises an isolated polypeptide, an isolated nucleic acid, an antigen presenting cell, an immune cell and/or an antibody; the isolated polypeptide has an amino acid sequence as shown in any one of SEQ ID NOs: 2, 3, 5, 6, 8, 9, 11, 13-15, 18-20, 22-24, 26-28, 30, and 32-36 or is a functional analog thereof.
Inventors:
LI BO (CN)
LI DONGLI (CN)
ZHANG LE (CN)
HUANG YING (CN)
LIU GENG (CN)
LI DONGLI (CN)
ZHANG LE (CN)
HUANG YING (CN)
LIU GENG (CN)
Application Number:
PCT/CN2022/120993
Publication Date:
November 30, 2023
Filing Date:
September 23, 2022
Export Citation:
Assignee:
SHENZHEN GINO BIOTECHNOLOGY CO LTD (CN)
GENOIMMUNE THERAPEUTICS CO LTD (CN)
GENOIMMUNE THERAPEUTICS CO LTD (CN)
International Classes:
C07K14/705; A61K39/00; A61P35/00; C12N5/0781; C12N5/0783; C12N5/0784; C12N5/0786; C12N9/02; C12N15/53
Foreign References:
| CN104056261A | 2014-09-24 | |||
| CN106749668A | 2017-05-31 | |||
| CN113045667A | 2021-06-29 | |||
| CN112601811A | 2021-04-02 | |||
| CN112074296A | 2020-12-11 | |||
| CN110392678A | 2019-10-29 |
Attorney, Agent or Firm:
ZHIFAN & PARTNERS (CN)
Download PDF: